As a long-time ally in the battle against mesothelioma, I’ve seen groundbreaking strides in creating a new cure for mesothelioma. Having witnessed the remarkable potential of enzyme therapy, which has quadrupled survival at 36 months compared to standard protocols, my optimism for treatment advancements is higher than ever1. In tandem, cutting-edge vaccines like UV1 are…